216 related articles for article (PubMed ID: 30458003)
1. TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis.
Meng C; Yin X; Liu J; Tang K; Tang H; Liao J
PLoS One; 2018; 13(11):e0207039. PubMed ID: 30458003
[TBL] [Abstract][Full Text] [Related]
2. Serum matrix metalloproteinase-9 level as a biomarker for colorectal cancer: a diagnostic meta-analysis.
Liang S; Chang L
Biomark Med; 2018 Apr; 12(4):393-402. PubMed ID: 29575908
[TBL] [Abstract][Full Text] [Related]
3. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Xu F; Xu L; Wang M; An G; Feng G
Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
[TBL] [Abstract][Full Text] [Related]
4. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
Jiang JX; Zhang N; Liu ZM; Wang YY
Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
[TBL] [Abstract][Full Text] [Related]
5. Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals.
Christensen IJ; Brünner N; Dowell B; Davis G; Nielsen HJ; Newstead G; King D
Anticancer Res; 2015 Sep; 35(9):4935-41. PubMed ID: 26254391
[TBL] [Abstract][Full Text] [Related]
6. Predictive power of circulating miRNAs in detecting colorectal cancer.
Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
[TBL] [Abstract][Full Text] [Related]
8. Plasma or serum TIMP-1 is a predictor of survival outcomes in colorectal cancer: a meta-analysis.
Lee JH; Choi JW; Kim YS
J Gastrointestin Liver Dis; 2011 Sep; 20(3):287-91. PubMed ID: 21961097
[TBL] [Abstract][Full Text] [Related]
9. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis.
Zuo Z; Jiang Y; Zeng S; Li Y; Fan J; Guo Y; Tao H
Pathol Res Pract; 2020 Oct; 216(10):153130. PubMed ID: 32853954
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysis.
Hu H; Zhou C; Li B; Chen Y; Dai J; Mao Y; Huang T; Yu H; Chen M; Zhao J; Duan S
Pathol Res Pract; 2018 Oct; 214(10):1572-1578. PubMed ID: 30082160
[TBL] [Abstract][Full Text] [Related]
11. Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals.
Nielsen HJ; Brünner N; Jorgensen LN; Olsen J; Rahr HB; Thygesen K; Hoyer U; Laurberg S; Stieber P; Blankenstein MA; Davis G; Dowell BL; Christensen IJ; ;
Scand J Gastroenterol; 2011 Jan; 46(1):60-9. PubMed ID: 20799911
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
Huang X; Lan Y; Li E; Li J; Deng Q; Deng X
J Int Med Res; 2021 May; 49(5):3000605211012570. PubMed ID: 33942633
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis.
Yuan Y; Qu B; Yan J; Wang H; Yin L; Han Q
Panminerva Med; 2015 Jun; 57(2):55-64. PubMed ID: 25256821
[TBL] [Abstract][Full Text] [Related]
14. Plasma Inter-Alpha-Trypsin Inhibitor Heavy Chains H3 and H4 Serve as Novel Diagnostic Biomarkers in Human Colorectal Cancer.
Jiang X; Bai XY; Li B; Li Y; Xia K; Wang M; Li S; Wu H
Dis Markers; 2019; 2019():5069614. PubMed ID: 31481982
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients.
Groblewska M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
Folia Histochem Cytobiol; 2010 Dec; 48(4):564-71. PubMed ID: 21478099
[TBL] [Abstract][Full Text] [Related]
16. Limited diagnostic value of microRNAs for detecting colorectal cancer: a meta-analysis.
Zhou XJ; Dong ZG; Yang YM; Du LT; Zhang X; Wang CX
Asian Pac J Cancer Prev; 2013; 14(8):4699-704. PubMed ID: 24083729
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic significance of TIMP-1 level in serum and its immunohistochemical expression in colorectal cancer patients.
Niewiarowska K; Pryczynicz A; Dymicka-Piekarska V; Gryko M; Cepowicz D; Famulski W; Kemona A; Guzińska-Ustymowicz K
Pol J Pathol; 2014 Dec; 65(4):296-304. PubMed ID: 25693084
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200 as potential diagnostic markers for colorectal cancer: meta-analysis and experimental validation.
Peng Z; Zhu W; Dai J; Ju F
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):77-85. PubMed ID: 29808805
[TBL] [Abstract][Full Text] [Related]
19. A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer.
Li C; He X; Zhang L; Li L; Zhao W
BMC Cancer; 2019 Oct; 19(1):957. PubMed ID: 31615475
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis.
Zhi ML; Liu ZJ; Yi XY; Zhang LJ; Bao YX
Genet Mol Res; 2015 Dec; 14(4):18018-25. PubMed ID: 26782449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
